Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-ndmmz Total loading time: 0 Render date: 2024-06-08T06:15:14.209Z Has data issue: false hasContentIssue false

17 - Therapeutic decision making in BMT/SCT for hemoglobinopathies

Published online by Cambridge University Press:  05 August 2013

By
Shalini Shenoy ,
Reinhold Munker  and
Kerry Atkinson
Edited by
Reinhold Munker ,
Gerhard C. Hildebrandt ,
Hillard M. Lazarus  and
Kerry Atkinson
Reinhold Munker
Affiliation:
Louisiana State University, Shreveport
Gerhard C. Hildebrandt
Affiliation:
University of Utah
Hillard M. Lazarus
Affiliation:
Ireland Cancer Center, Case Western Reserve University Hospital, Cleveland
Kerry Atkinson
Affiliation:
University of Queensland
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
The BMT Data Book
Including Cellular Therapy
 , pp. 179 - 191
Publisher: Cambridge University Press
Print publication year: 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bernardo, ME, Piras, E, Vacca, A, et al. 2012. Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan. Blood 120: 473–476.CrossRefGoogle ScholarPubMed
Brodsky, RA, Luznik, L, Bolaños-Meade, J, et al. 2008. Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases. Bone Marrow Transplant 42: 523–527.CrossRefGoogle ScholarPubMed
Fitzhugh, CD, Lauder, N, Jonassaint, JC, et al. 2010. Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease. Am J Hematol 85: 36–40.Google ScholarPubMed
Fitzhugh, CD, Perl, S, Hsieh, MM. 2008. Late effects of myeloablative bone marrow transplantation (BMT) in sickle cell disease (SCD). Blood 111: 1742–1743.CrossRefGoogle Scholar
Gaziev, J & Lucarelli, G. 2003. Stem cell transplantation for hemoglobinopathies. Curr Op Pediatr 15: 24–31.CrossRefGoogle ScholarPubMed
Hsieh, MH, Fitzhugh, CD, & Tisdale, JF. 2011. Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now. Blood 118: 1197–1207.CrossRefGoogle ScholarPubMed
Hsieh, MM, Kang, EM, Fitzhugh, CD, et al. 2009. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med 361: 2309–2317.CrossRefGoogle ScholarPubMed
Hulbert, ML, McKinstry, RC, Lacey, JL, et al. 2011. Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. Blood 117: 772–779.CrossRefGoogle ScholarPubMed
Jacobsohn, DA, Duerst, R, Tse, W, et al. 2004. Reduced intensity haematopoietic stem-cell transplantation for treatment of non-malignant diseases in children. Lancet 364: 156–162.CrossRefGoogle ScholarPubMed
Kamani, NR, Walters, MC, Carter, S, et al. 2012. Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biol Blood Marrow Transplant 18: 1265–1272.CrossRefGoogle Scholar
La Nasa, G, Caocci, G, Argiolu, F, et al. 2005. Unrelated donor stem cell transplantation in adult patients with thalassemia. Bone Marrow Transplant 36: 971–975.CrossRefGoogle ScholarPubMed
Locatelli, F, Rocha, V, Reed, W, et al. 2003. Related umbilical cord transplantation in patients with thalassemia. Blood 101: 2137–2143.CrossRefGoogle ScholarPubMed
Olivieri, NF, Nathan, DG, MacMillan, JH, et al. 1994. Survival in medically treated people with homozygous beta-thalassemia. N Engl J Med 331: 574–578.CrossRefGoogle ScholarPubMed
Panepinto, JA, Walters, MC, Carreras, J, et al. 2007. Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Br J Haematol 137: 479–485.CrossRefGoogle ScholarPubMed
Powars, DR, Chan, LS, Hiti, A, et al. 2005. Outcome of sickle cell anemia. A 4 decade observational study of 1056 patients. Medicine 84: 363–376.CrossRefGoogle ScholarPubMed
Ruggeri, A, Eapen, M, Scaravadou, A, et al. 2011. Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Eurocord Registry; Center for International Blood and Marrow Transplant Research; New York Blood Center. Biol Blood Marrow Transplant 17: 1375–1382.CrossRefGoogle ScholarPubMed
Shenoy, S. 2011. Hematopoietic stem cell transplantation for sickle cell disease: current practice and emerging trends. Hematology Am Soc Hematol Educ Program 2011: 273–279.
Shenoy, S, Grossman, WJ, di Persio, J, et al. 2005. A novel reduced-intensity stem cell transplant regimen for non-malignant disorders. Bone Marrow Transplant 35: 345–352.CrossRefGoogle Scholar
Sodani, P, Gaziev, D, Polchi, P, et al. 2004. New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. Blood 104: 1201–1203.CrossRefGoogle ScholarPubMed
Walters, MC. 2005. Stem cell therapy for sickle cell disease: transplantation and gene therapy. Hematology Am Soc Hematol Educ Program 2005: 66–73.
Walters, MC, Hardy, K, Edwards, S, et al. 2010. Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. Multicenter Study of Bone Marrow Transplantation for Sickle Cell Disease. Biol Blood Marrow Transplant 16: 263–272.CrossRefGoogle ScholarPubMed
Walters, MC, Patience, M, Leisenring, W, et al. 2001. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 7: 665–673.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×